Shi S, Ou X, Liu C, Li R, Zheng Q, Hu L
Front Immunol. 2025; 16:1518664.
PMID: 39949765
PMC: 11821961.
DOI: 10.3389/fimmu.2025.1518664.
Okamura K, Sato M, Suzuki T, Nohara K
Environ Health Prev Med. 2025; 29:74.
PMID: 39756915
PMC: 11701098.
DOI: 10.1265/ehpm.24-00139.
Gu L, Zhu Y, Nandi S, Lee M, Watari K, Bareng B
Nature. 2025; 637(8045):461-469.
PMID: 39743585
DOI: 10.1038/s41586-024-08317-9.
Nature. 2025; .
PMID: 39743551
DOI: 10.1038/d41586-024-04137-z.
Gawi Ermi A, Sarkar D
Cancers (Basel). 2024; 16(23).
PMID: 39682130
PMC: 11640171.
DOI: 10.3390/cancers16233944.
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.
Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y
Mol Cancer. 2024; 23(1):261.
PMID: 39574178
PMC: 11580516.
DOI: 10.1186/s12943-024-02165-x.
Nanomedicine Strategies Utilizing Lipid-Based Nanoparticles for Liver Cancer Therapy: Exploring Signaling Pathways and Therapeutic Modalities.
Asgharzadeh F, Moradi Binabaj M, Fanoudi S, Cho W, Yang Y, Azarian M
Adv Pharm Bull. 2024; 14(3):513-523.
PMID: 39494254
PMC: 11530870.
DOI: 10.34172/apb.2024.061.
Inflammation and Immunity in Liver Neoplasms: Implications for Future Therapeutic Strategies.
Kim J, Seki E
Mol Cancer Ther. 2024; 24(2):188-199.
PMID: 39365846
PMC: 11794036.
DOI: 10.1158/1535-7163.MCT-23-0726.
Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments.
Li W, Chen G, Peng H, Zhang Q, Nie D, Guo T
Biomolecules. 2024; 14(9).
PMID: 39334927
PMC: 11430656.
DOI: 10.3390/biom14091161.
Diagnostic value of expressions of cancer stem cell markers for adverse outcomes of hepatocellular carcinoma and their associations with prognosis: A Bayesian network meta‑analysis.
Ou Z, Fu S, Yi J, Huang J, Zhu W
Oncol Lett. 2024; 28(5):536.
PMID: 39290959
PMC: 11406626.
DOI: 10.3892/ol.2024.14669.
Insights into the Correlation between Toll-Like Receptor 2 Polymorphism and HBV-Related Disease Progression and Occurrence of Hepatocellular Carcinoma: A Case-Control Study in Egyptian Patients.
Elabd N, Helal M, Elkhayat M, Abd-ElKhalek H, Ahmed D, El-Shemy A
Can J Infect Dis Med Microbiol. 2024; 2024:5797895.
PMID: 39071840
PMC: 11281855.
DOI: 10.1155/2024/5797895.
NF-κB role on tumor proliferation, migration, invasion and immune escape.
Khan A, Zhang Y, Ma N, Shi J, Hou Y
Cancer Gene Ther. 2024; 31(11):1599-1610.
PMID: 39033218
DOI: 10.1038/s41417-024-00811-6.
Liver cancer initiation requires translational activation by an oncofetal regulon involving LIN28 proteins.
Hsieh M, Wei Y, Li L, Nguyen L, Lin Y, Yong J
J Clin Invest. 2024; 134(15).
PMID: 38875287
PMC: 11290964.
DOI: 10.1172/JCI165734.
Deep learning-based pathway-centric approach to characterize recurrent hepatocellular carcinoma after liver transplantation.
To J, Ghosh S, Zhao X, Pasini E, Fischer S, Sapisochin G
Hum Genomics. 2024; 18(1):58.
PMID: 38840185
PMC: 11151487.
DOI: 10.1186/s40246-024-00624-6.
Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring.
Sun J, Esplugues E, Bort A, Cardelo M, Ruz-Maldonado I, Fernandez-Tussy P
Nat Metab. 2024; 6(4):741-763.
PMID: 38664583
DOI: 10.1038/s42255-024-01019-6.
Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
Ma Y, Lv H, Xing F, Xiang W, Wu Z, Feng Q
Front Med. 2024; 18(3):430-445.
PMID: 38600350
DOI: 10.1007/s11684-023-1049-z.
Molecular mechanisms in MASLD/MASH-related HCC.
Wang X, Zhang L, Dong B
Hepatology. 2024; .
PMID: 38349726
PMC: 11323288.
DOI: 10.1097/HEP.0000000000000786.
Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis.
Savage T, Fortson K, de Los Santos-Alexis K, Oliveras-Alsina A, Rouanne M, Rae S
Immunity. 2024; 57(2):303-318.e6.
PMID: 38309273
PMC: 10922825.
DOI: 10.1016/j.immuni.2024.01.009.
The Past and Future of Inflammation as a Target to Cancer Prevention.
Antonucci L, Karin M
Cancer Prev Res (Phila). 2024; 17(4):141-155.
PMID: 38271694
PMC: 10987280.
DOI: 10.1158/1940-6207.CAPR-23-0423.
Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer.
Fu X, Zhang Y, Luo Q, Ju Y, Song G
Cancer Biol Med. 2023; 20(11).
PMID: 38009775
PMC: 10690881.
DOI: 10.20892/j.issn.2095-3941.2023.0229.